PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Diabetes Research Center (DRC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, Qatar.\', \'Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull, United Kingdom.\', \'Department of Endocrinology, Leeds Medical School, Leeds, United Kingdom.\', \'Research Department, Royal College of Surgeons in Ireland Bahrain, Adliya, Bahrain.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fendo.2021.658304
?:hasPublicationType
?:journal
  • Frontiers in endocrinology
is ?:pmid of
?:pmid
?:pmid
  • 34248840
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.79
?:rankingScore_hIndex
  • 42
is ?:relation_isRelatedTo_publication of
?:title
  • Type 2 Diabetes Coagulopathy Proteins May Conflict With Biomarkers Reflective of COVID-19 Severity.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all